FERMENTALG (FALG.PA)

FR0011271600 - Common Stock

0.56  -0.05 (-8.05%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to FALG. FALG was compared to 66 industry peers in the Chemicals industry. The financial health of FALG is average, but there are quite some concerns on its profitability. FALG is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

FALG had negative earnings in the past year.
FALG had a negative operating cash flow in the past year.
In the past 5 years FALG always reported negative net income.
FALG had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

FALG has a worse Return On Assets (-17.18%) than 90.48% of its industry peers.
FALG has a Return On Equity of -27.38%. This is amonst the worse of the industry: FALG underperforms 82.54% of its industry peers.
Industry RankSector Rank
ROA -17.18%
ROE -27.38%
ROIC N/A
ROA(3y)-14.94%
ROA(5y)-22.44%
ROE(3y)-23.99%
ROE(5y)-37.74%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

FALG has a worse Gross Margin (23.21%) than 65.08% of its industry peers.
The Profit Margin and Operating Margin are not available for FALG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

FALG does not have a ROIC to compare to the WACC, probably because it is not profitable.
FALG has more shares outstanding than it did 1 year ago.
FALG has more shares outstanding than it did 5 years ago.
FALG has a worse debt/assets ratio than last year.

2.2 Solvency

FALG has an Altman-Z score of 0.67. This is a bad value and indicates that FALG is not financially healthy and even has some risk of bankruptcy.
FALG has a worse Altman-Z score (0.67) than 87.30% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that FALG is not too dependend on debt financing.
FALG has a Debt to Equity ratio of 0.43. This is comparable to the rest of the industry: FALG outperforms 52.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z 0.67
ROIC/WACCN/A
WACC5.28%

2.3 Liquidity

FALG has a Current Ratio of 5.35. This indicates that FALG is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.35, FALG belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
FALG has a Quick Ratio of 3.76. This indicates that FALG is financially healthy and has no problem in meeting its short term obligations.
FALG has a Quick ratio of 3.76. This is amongst the best in the industry. FALG outperforms 90.48% of its industry peers.
Industry RankSector Rank
Current Ratio 5.35
Quick Ratio 3.76

5

3. Growth

3.1 Past

FALG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.64%.
The Revenue for FALG has decreased by -43.16% in the past year. This is quite bad
FALG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 114.10% yearly.
EPS 1Y (TTM)-32.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.89%
Revenue 1Y (TTM)-43.16%
Revenue growth 3Y59.41%
Revenue growth 5Y114.1%
Sales Q2Q%-55.35%

3.2 Future

FALG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.96% yearly.
Based on estimates for the next years, FALG will show a very strong growth in Revenue. The Revenue will grow by 29.38% on average per year.
EPS Next Y4%
EPS Next 2Y9.54%
EPS Next 3Y13.96%
EPS Next 5YN/A
Revenue Next Year-49.05%
Revenue Next 2Y12.86%
Revenue Next 3Y29.38%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FALG. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FALG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as FALG's earnings are expected to grow with 13.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.54%
EPS Next 3Y13.96%

0

5. Dividend

5.1 Amount

No dividends for FALG!.
Industry RankSector Rank
Dividend Yield N/A

FERMENTALG

EPA:FALG (4/15/2024, 7:00:00 PM)

0.56

-0.05 (-8.05%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap30.22M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.18%
ROE -27.38%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 23.21%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.35
Quick Ratio 3.76
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-32.64%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y4%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-43.16%
Revenue growth 3Y59.41%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y